Q3 CooperVision organic growth was 2% vs. ~5% expected, driven by accelerated private-label Clarity drawdown in Asia Pac and normalization of six-month to two-month e-commerce channel inventory in China; Q4 guidance is conservatively built to offset these factors.
MyDay supply constraints have been fully resolved as of May, enabling double-digit MyDay growth and supporting ~25% global market share in daily silicone hydrogel lenses.
Management expects the global contact lens market to grow 4–6% in FY26, CooperVision core in line with market plus 100 bps from MiSight, with daily wear penetration at ~40% globally and runway to 50%+.
Targeting $2 billion of free cash flow over three years, with declining CapEx; primary uses include debt paydown and increased share repurchases, supported by a CooperSurgical reorganization to improve margins and offset ~$24 million in tariffs.

Sep 3, 2025, 8:18 PM

Cooper Companies Inc Presents Growth Strategies at William Blair Conference

COO

Guidance Update

Product Launch

New Projects/Investments

Global Focus: Cooper Companies Inc, a global medical device firm, highlighted its dual focus on vision (contact lenses including a broad range of toric and multifocal lenses) and women's health (fertility and OB/GYN surgical products).
Guidance & Market Dynamics: The company updated its guidance due to evolving market conditions and inventory dynamics, with expectations for lower contact lens market growth compared to past projections.
Product & Investment Initiatives: Emphasis was placed on new product initiatives, such as the launch of the Energous offering and aggressive strategies around MiSight for myopia control, alongside significant capacity investments for manufacturing and distribution.

Jun 5, 2025, 6:02 PM

Cooper Cos: OECD Downgrades Global Growth Outlook on Trump Tariffs

COO

The OECD cut global GDP growth forecasts to 2.9% for both 2025 and 2026, down from previous projections above 3%.
The US economy is projected to slow to 1.6% in 2025 and 1.5% in 2026 as higher tariffs dampen investment, consumer spending, and job growth.
The US effective tariff rate on imports has jumped to 15.4%, its highest level since 1938, which is expected to weigh on consumption and business investment.
The OECD warned that rising trade barriers and policy uncertainty have undermined confidence, urging constructive negotiations to stabilize global markets.

Jun 3, 2025, 7:08 AM

Cooper Companies: Iran Uranium Surge Spurs US Nuclear Deal Proposal

COO

Iran’s 60% enriched uranium stockpile rose by about 50%, from 274.8 kg to 408.6 kg, enough for roughly 10 nuclear weapons.
The US proposed a new nuclear deal via Omani mediation, demanding an end to Iran’s enrichment in exchange for phased sanctions relief; Iran rejected halting enrichment as one-sided.
The US has paused new sanctions pending Iran’s response, though President Trump warned of military action if talks fail and urged Israel not to strike Iranian sites.
Regional tensions persist, with reports that Israel may consider unilateral action against Iran’s nuclear facilities.

May 30, 2025, 3:19 PM

Cooper Companies Q2 2025 Earnings Guidance Update

COO

Earnings

Guidance Update

Revised fiscal 2025 guidance: Total revenue is expected to be between $4,107 and $4,146 million with organic growth of 5%-6%.
Segment details: CooperVision is guided to deliver revenue between $2,759 and $2,786 million with 6%-7% organic growth, while CooperSurgical’s revenue guidance is $1,347 to $1,359 million with 3.5%-4.5% growth; non-GAAP EPS is projected to be between $4.05 and $4.11.

May 29, 2025, 9:00 PM

Filings & Transcripts

Recent SEC filings and earnings call transcripts for COO.

No recent filings or transcripts found for COO.